Healios K.K. | Mutual Funds
Mutual Funds that own Healios K.K.
JPM Asset JPM The Japan Mother Fund
2,111,899
4.29%
1,362,900
1.99%
03/26/2018
Baillie Gifford Overseas Growth Fund - Japanese Smaller Cos.
824,100
1.67%
0
1.33%
04/30/2018
Matthews Asia Growth Fund
380,100
0.77%
0
0.55%
06/29/2018
Baillie Gifford Shin Nippon Plc
354,700
0.72%
70,600
0.99%
10/31/2017
AXA Framlington Japan Fund
204,200
0.42%
37,700
0.98%
02/15/2018
Baillie Gifford Japan Trust Plc
166,700
0.34%
0
0.27%
10/31/2017
DIAM (Japan) Emerging Market Japanese Equity Fund
125,200
0.25%
-9,800
1.33%
04/17/2017
Simplex Asset J Flag Small Cap Fund (FoFs) (Inst)
117,000
0.24%
67,000
0.89%
09/20/2016
Kokusai Japanese Dream Open Fund
101,599
0.21%
97,599
0.99%
02/26/2018
93,800
0.19%
93,800
1.34%
09/30/2017
| Address |
World Trade Center Building, 15/F
Tokyo Tokyo 105
Japan
|
|
Employees
|
- |
| Website |
http://www.healios.co.jp |
| Updated |
07/08/2019 |
| Healios KK engages in the development and sale of ophthalmological surgery adjuvants. It aims to commercialize pharmaceutical hiPSC derived retinal pigment epithelium (RPE) cell transplantation for the treatment of age-related macular degeneration. The firm develops therapies for the regeneration of retinal function and to improve visual function in those affected with retinal degenerative diseases. |
